Bringing the fundamentals into focus…
Back to Ocular Therapeutix, Inc.
How Ocular Therapeutix, Inc. stacks up
OCUL · against 411 other Healthcare companies of similar size
Growth
18/ 100
Near the bottom of its peers.
Ranked #346 of 412 · scores higher than 16% of peers
Bars: peers in each 10-point band of the growth score40 peers with a growth score of 10–19, including OCUL · Click a bar to see the companies
Why growth scores 18?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings per share growth, revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- slower revenue growth over the last year: weaker than 82% of peers. Revenue growth: -8.1% vs peer median 6.1%
- slower revenue growth over three years: weaker than 75% of peers. 3-year revenue growth: -1.6% vs peer median 5.8%
Metric by metric
Position: dot = OCUL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | OCUL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 416 reported | -8.1% | 5.9% | 17% | 33% | |
| Earnings per share growthHigher is better · 225 reported | Not reported | 9.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 404 reported | -1.6% | 6.8% | 23% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around OCUL| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 2.8B USD | 99 | 51 | |
| 340 | 7.1B CNY (≈$998M) | 19 | 49 | |
| 340 | 9.9B CNY (≈$1.4B) | 19 | 50 | |
| 340 | 1.2B USD | 19 | 39 | |
| 340 | 966M USD | 19 | 33 | |
| 346 | 1.5B USD | 18 | 30 | |
| 347 | 12.2B CNY (≈$1.7B) | 17 | 39 | |
| 347 | 7.1B CNY (≈$989M) | 17 | 38 | |
| 347 | 12.8B CNY (≈$1.8B) | 17 | 36 | |
| 347 | 2.0B USD | 17 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score